Long-Term Debt: The sum of all long term debt fields.
Sutro Biopharma, Inc. (STRO) Long-Term Debt data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$102.48M |
|
$-191.09M |
|
-- |
|
$102.48M |
|
$260.85M |
|
$-158.37M |
|
$-32.81M |
|
$-191.18M |
|
$-191.18M |
|
$-191.09M |
|
$-191.09M |
|
$-191.09M |
|
$-191.09M |
|
$-158.37M |
|
$-154.48M |
|
8.50M |
|
8.50M |
|
$-22.49 |
|
$-22.49 |
|
| Balance Sheet Financials | |
$150.93M |
|
$10.65M |
|
$22.90M |
|
$173.83M |
|
$75.13M |
|
|
Long-Term Debt |
-- |
$231.15M |
|
$306.28M |
|
$-132.45M |
|
$-132.45M |
|
$-132.45M |
|
8.58M |
|
| Cash Flow Statement Financials | |
$-177.23M |
|
$45.01M |
|
$0.04M |
|
$191.16M |
|
$58.99M |
|
$-132.17M |
|
$14.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-154.53% |
|
-154.53% |
|
-150.73% |
|
-186.55% |
|
-186.45% |
|
$-178.93M |
|
-- |
|
-- |
|
-- |
|
0.59 |
|
-- |
|
25.77 |
|
14.16 |
|
144.27% |
|
144.27% |
|
-109.93% |
|
144.27% |
|
$-15.43 |
|
$-21.06 |
|
$-20.86 |
|